In silico identification and validation of phenolic lipids as potential inhibitor against bacterial and viral strains

The recurrence of coronavirus disease and bacterial resistant strains has drawn attention to naturally occurring bioactive molecules that can demonstrate broad-spectrum efficacy against bacteria as well as viral strains. The drug-like abilities of naturally available "anacardic acids" (AA) and their derivatives against different bacterial and viral protein targets through in-silico tools were explored. Three viral protein targets [P DB: 6Y2E (SARS-CoV-2), 1AT3 (Herpes) and 2VSM (Nipah)] and four bacterial protein targets [P DB: 2VF5 (Escherichia coli), 2VEG (Streptococcus pneumoniae), 1JIJ (Staphylococcus aureus) and 1KZN (E. coli)] were selected to evaluate the activity of bioactive AA molecules. The potential ability to inhibit the progression of microbes has been discussed based on the structure, functionality and interaction ability of these molecules on the selected protein targets for multi-disease remediation. The number of interactions, full-fitness value and energy of the ligand-target system were determined from the docked structure in SwissDock and Autodock Vina. In order to compare the efficacy of these active derivatives to that of commonly used drugs against bacteria and viruses, a few of the selected molecules were subjected to 100 ns long MD simulations. It was found that the phenolic groups and alkyl chains of AA derivatives are more likely to bind with microbial targets, that could be responsible for the improved activity against these targets. The results suggest that the proposed AA derivatives have demonstrated potential to become active drug ingredients against microbial protein targets. Further, experimental investigations are essential for clinical verification of the drug-like abilities of AA derivatives.Communicated by Ramaswamy H. Sarma.

Development of Hydrophobic, Anticorrosive, Nanocomposite Polymeric Coatings from Canola Oil: A Sustainable Resource

A novel hydrophobic Canola oil-based nanocomposite anticorrosive coating material with different contents of fumes silica (FS) was successfully synthesized via an in situ method. Firstly, a Canola oil-based hydroxyl terminated poly (oxalate-amide) was prepared by a two-step process of amidation and condensation. Secondly, the dispersion of fumed silica (1 to 3 wt.%) in hydroxyl terminated poly (oxalate-amide) was carried out, followed by reaction with toluene-2,4- diisocyanate (TDI) in order to form poly (urethane-oxalate-amide)/fumed silica nanocomposite. The structure and properties of nanocomposite were analyzed by FTIR, NMR (¹H/¹³C), TGA/DTA, DSC, contact angle, and SEM. The physico-mechanical and electrochemical tests were performed in order to check the performance of nanocomposite coating. The results reveal that FS is homogenously dispersed in poly (urethane-oxalate-amide) matrix with a loading amount of less than 3 wt.%. The performance of nanocomposite coating improved when compared to virgin polymer. The synthesized nanocomposite coating can be used in the field of hydrophobic anticorrosive coatings.

Physicochemical and Pharmacokinetic Analysis of Anacardic Acid Derivatives

Anacardic acid (AA) and its derivatives are well-known for their therapeutic applications ranging from antitumor, antibacterial, antioxidant, anticancer, and so forth. However, their poor pharmacokinetic and safety properties create significant hurdles in the formulation of the final drug molecule. As a part of our endeavor to enhance the potential and exploration of the anticancer activities, a detailed study on the properties of selected AA derivatives was performed in this work. A comprehensive analysis of the drug-like properties of 100 naturally occurring AA derivatives was performed, and the results were compared with certain marketed anticancer drugs. The work focused on the understanding of the interplay among eight physicochemical properties. The relationships between the physicochemical properties, absorption, distribution, metabolism, and excretion attributes, and the in silico toxicity profile for the set of AA derivatives were established. The ligand efficacy of the finally scrutinized 17 AA derivatives on the basis of pharmacokinetic properties and toxicity parameters was further subjected to dock against the potential anticancer target cyclin-dependent kinase 2 (PDB ID: 1W98). In the docked complex, the ligand molecules (AA derivatives) selectively bind with the target residues, and a high binding affinity of the ligand molecules was ensured by the full fitness score using the SwissDock Web server. The BOILED-Egg model shows that out of 17 scrutinized molecules, 3 molecules exhibit gastrointestinal absorption capability and 14 molecules exhibit permeability through the blood-brain barrier penetration. The analysis can also provide some useful insights to chemists to modify the existing natural scaffolds in designing new anacardic anticancer drugs. The increased probability of success may lead to the identification of drug-like candidates with favorable safety profiles after further clinical evaluation.